BioPharm International
March 02, 2021
Cover Story
34
3
In a pandemic, genetic vaccines offer several advantages over traditional approaches.
March 02, 2021
Development
34
3
Despite the persistence of the patent thicket, and slow uptake by the medical community, biosimilars are positioned for growth in the US.
March 02, 2021
Upstream Processing
34
3
Overcoming time and cost constraints can help enable seed train intensification efforts to maximize product yield.
March 02, 2021
Downstream Processing
34
3
The need for real-time monitoring and control has spurred the development of new analytical tools.
March 01, 2021
Manufacturing
34
3
Homology Medicines discusses how the clinical-stage biopharmaceutical company met its need for supply of adeno-associated virus vectors.
March 01, 2021
Manufacturing
34
3
While manufacturing increases have been implemented for vials and syringes, meeting future market needs remains unpredictable.
March 01, 2021
Analytics
34
3
Accelerated drug development timelines must accommodate all crucial elements of nonclinical safety studies.
March 01, 2021
Regulatory Beat
34
3
Reviews of FDA initiatives and activities recapitulate efforts to assess and approve new drugs, generic drugs, and biologics and strategies for advancing new initiatives.
March 01, 2021
From the Editor
34
3
Bio/pharma works hard today to change the calendar to tomorrow.
March 01, 2021
Ask The Expert
34
3
Auditing distribution suppliers provides understanding and documentation of the services performed.